The report highlights Daewoong Pharmaceutical's commitment to becoming a global healthcare group that fulfills its corporate social responsibility. The report features a materiality assessment and focuses on the company's achievements and plans in three areas: R&D and innovation, drug safety and quality, and securing talent and improving organizational culture. Daewoong Pharmaceutical also highlights its commitment to sustainability, with a focus on climate change, environmental impact, and corporate governance. The report is the first in a series of annual reports that will be published by the company to demonstrate transparency and accountability.
Issuing Company Daewoong Pharma Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 4.89 MB
No. of Pages 108 pages
Reporting period2022
Report Edition1
Assurance Provider Korean Standards Association
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue